The license agreements, first entered into in 2004 and amended in 2005, granted ISCO access to a range of ACT's patents and patent applications for the use of various technologies in a limited set of human tissues.
http://www.marketwire.com/press-release/international-stem-cell-corporation-strengthens-intellectual-property-portfolio-otcqb-isco-1757458.htm
http://www.marketwire.com/press-release/international-stem-cell-corporation-strengthens-intellectual-property-portfolio-otcqb-isco-1757458.htm
No comments:
Post a Comment